Coastlands Capital LP - Significant Ownership

Signature - Title
/s/ Mark Shamia - Chief Operating Officer of the General Partner, Coastlands Capital LLC
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Coastlands Capital LP.

Notify me when Coastlands Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Coastlands Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CAMP Camp4 Therapeutics Corp Common stock, par value $0.0001 per share 10% $9.87M 4.89M Coastlands Capital LP Sep 10, 2025
XFOR X4 Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.99% $7.77M $37.4K 2.49M +0.48% Coastlands Capital LP Oct 3, 2025
ELDN Eledon Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.98% $20.7M 4.76M Matthew D. Perry Nov 19, 2025
WHWK Whitehawk Therapeutics, Inc. Common stock 5.98% $4.82M 2.82M Coastlands Capital LP Aug 19, 2025
NEUP Neuphoria Therapeutics Inc. Common Stock, par value $0.00001 per share 5.1% $1.42M 120K Coastlands Capital LP Nov 5, 2025

Schedules 13D/G Reported by Coastlands Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.